# OnCo record paper-ying-cancer-med (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-ying-cancer-med/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-ying-cancer-med" ;
  schema:name "Relmacabtagene autoleucel (relma-cel) CD19 CAR-T therapy for adults with heavily pretreated relapsed/refractory large B-cell lymphoma in China"@en ;
  schema:description "Paper cited by one trial page and one treatment page, indexed on Europe PMC as PubMed record 33382529 and published in Cancer medicine; the citing pages link this DOI, which is how the record was matched."@en ;
  schema:url <https://onco.cc/key-papers/paper-ying-cancer-med/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1002/cam4.3686>, <https://pubmed.ncbi.nlm.nih.gov/33382529/>, <https://europepmc.org/article/MED/33382529> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1002/cam4.3686> ;
  schema:datePublished "2021"^^xsd:gYear ;
  schema:author "Ying Z, Yang H, Guo Y, et al." ;
  onco:related <https://onco.cc/drugs/relmacabtagene-autoleucel/> ;
  onco:trials <https://onco.cc/trials/reliance/> ;
  onco:journals <https://onco.cc/journals/cancer-medicine/> .